SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-051131
Filing Date
2023-10-02
Accepted
2023-10-02 17:08:23
Documents
2
Period of Report
2023-10-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1594
2 EX-24 DOCUMENT attachment1.htm EX-24 3967
  Complete submission text file 0001209191-23-051131.txt   7168
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Issuer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ELEDON PHARMACEUTICALS, INC. 19900 MACARTHUR BLVD., SUITE 550 IRVINE CA 92612
Business Address
Kirk Allan (Reporting) CIK: 0001995409 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36620 | Film No.: 231300582